Necrotising enterocolitis in preterm infants: epidemiology and antibiotic consumption in the Polish neonatology network neonatal intensive care units in 2009

PLoS One. 2014 Mar 21;9(3):e92865. doi: 10.1371/journal.pone.0092865. eCollection 2014.

Abstract

The aim of this study was to describe the epidemiology of necrotising enterocolitis (NEC), antibiotic consumption and the usefulness of microbiological tests in very low birth weight (VLBW) Polish newborns.

Methods: Prospective surveillance was performed in the year 2009 by local infection control teams. The study covered 910 infants hospitalized in six Polish neonatal intensive care units. Two kinds of indicators were used for the description of antibiotic usage: the duration of treatment (days of treatment, DOTs) and the defined daily dose (DDD).

Results: NEC incidence was 8.7% and fatality rate was 19%. Chorioamnionitis, late gestational age and low birth weight were identified as risk factors for NEC. Catheterization, mechanical ventilation and other selected procedures were used considerably longer in newborns with NEC than in the remaining neonates. Total usage of antibiotics reached 2.9 DDDs or 1.437 days; the average use of drugs per case of NEC amounted to 0.47 DDD or 23.2 DOTs. The level of antibiotic usage was analysed with correlation to microbiological tests performed and it was non-significantly greater in the group of children with NEC in whom the tests were performed.

Conclusions: A high risk of developing NEC is closely associated with VLBW and with inflammation of the amnion during labour. We observed no relationship between the consumption of antibiotics in neonates with NEC and positive results of microbiological testing indicating sepsis accompanying NEC or gut colonization with pathogens.

Publication types

  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Enterocolitis, Necrotizing / diagnosis
  • Enterocolitis, Necrotizing / drug therapy
  • Enterocolitis, Necrotizing / epidemiology*
  • Enterocolitis, Necrotizing / microbiology
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Infant, Premature*
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / epidemiology*
  • Intensive Care Units, Neonatal
  • Male
  • Patient Outcome Assessment
  • Poland
  • Prospective Studies
  • Public Health Surveillance
  • Risk Factors

Substances

  • Anti-Bacterial Agents

Grants and funding

The authors have no support or funding to report.